• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用包裹树枝状卟啉的聚合物胶束进行光动力疗法治疗角膜新生血管。

Photodynamic therapy for corneal neovascularization using polymeric micelles encapsulating dendrimer porphyrins.

作者信息

Sugisaki Kenji, Usui Tomohiko, Nishiyama Nobuhiro, Jang Woo-Dong, Yanagi Yasuo, Yamagami Satoru, Amano Shiro, Kataoka Kazunori

机构信息

Department of Ophthalmology, Faculty of Medicine, University of Tokyo, Hongo, Bunkyo-ku, Japan

出版信息

Invest Ophthalmol Vis Sci. 2008 Mar;49(3):894-9. doi: 10.1167/iovs.07-0389.

DOI:10.1167/iovs.07-0389
PMID:18326709
Abstract

PURPOSE

To investigate the accumulation of new photosensitizers (PSs), dendrimer porphyrin (DP, free DP), and DP encapsulation into polymeric micelles (DP-micelle) and the efficacy of photodynamic therapy (PDT) in an experimental corneal neovascularization model in mice.

METHODS

Corneal neovascularization was induced by suturing 10-0 nylon 1 mm away from the limbal vessel in C57BL6/J mice. To determine the accumulation of free DP and DP-micelle, 10 mg/kg free DP or DP-micelle was administered by intravenous injection 4 days after suture placement. Mice were killed 1, 4, 24, and 168 hours after the injection of PS. Twenty-four hours after the administration of free DP or DP-micelle, mice were treated with a diode laser of 438-nm wavelength at 10 or 50 J/cm(2). Fluorescein angiography was performed before and 7 days after irradiation, and the area of corneal neovascularization was quantified.

RESULTS

Free DP and DP-micelle accumulated in the neovascularized area 1 hour to 24 hours after administration. Fluorescence of DP was weaker than that of DP-micelle. Neither DP-micelle nor DP could be detected in normal limbal vasculature. In the PDT experiments using PS, mean residual rates of corneal neovascularization were 10.1% in the mice treated with DP-micelle and 21.6% in the mice treated with free DP at 10 J/cm(2) (P < 0.01). At 50 J/cm(2), mean residual rates of corneal neovascularization were 10.6% in the mice treated with DP-micelle and 13.7% in the mice treated with free DP (P > 0.05). Although corneal neovascularization in PDT-treated mice exhibited significant regression compared with the control group, significant energy-related vessel regression with increasing laser energy could not be observed.

CONCLUSIONS

PDT with DP-micelle and free DP can provide efficacious treatment of corneal neovascularization.

摘要

目的

研究新型光敏剂(PSs)、树枝状卟啉(DP,游离DP)在小鼠实验性角膜新生血管模型中的蓄积情况以及其包裹于聚合物胶束(DP-胶束)中的情况,同时研究光动力疗法(PDT)的疗效。

方法

在C57BL6/J小鼠中,于距角膜缘血管1mm处缝合10-0尼龙线诱导角膜新生血管形成。为确定游离DP和DP-胶束的蓄积情况,在缝线放置4天后通过静脉注射给予10mg/kg游离DP或DP-胶束。在注射PS后1、4、24和168小时处死小鼠。在给予游离DP或DP-胶束24小时后,用波长438nm的二极管激光以10或50J/cm²进行治疗。在照射前和照射后7天进行荧光素血管造影,并对角膜新生血管面积进行定量分析。

结果

游离DP和DP-胶束在给药后1小时至24小时在新生血管区域蓄积。DP的荧光比DP-胶束的荧光弱。在正常角膜缘血管系统中未检测到DP-胶束和DP。在使用PS的PDT实验中,在10J/cm²时,用DP-胶束治疗的小鼠角膜新生血管的平均残留率为10.1%,用游离DP治疗的小鼠为21.6%(P<0.01)。在50J/cm²时,用DP-胶束治疗的小鼠角膜新生血管的平均残留率为10.6%,用游离DP治疗的小鼠为13.7%(P>0.05)。尽管与对照组相比,PDT治疗的小鼠角膜新生血管有显著消退,但未观察到随着激光能量增加而出现的与能量相关的血管显著消退。

结论

用DP-胶束和游离DP进行的PDT可有效治疗角膜新生血管。

相似文献

1
Photodynamic therapy for corneal neovascularization using polymeric micelles encapsulating dendrimer porphyrins.使用包裹树枝状卟啉的聚合物胶束进行光动力疗法治疗角膜新生血管。
Invest Ophthalmol Vis Sci. 2008 Mar;49(3):894-9. doi: 10.1167/iovs.07-0389.
2
Photodynamic therapy for corneal neovascularization using topically administered ATX-S10 (Na).
Ophthalmic Surg Lasers. 2000 Jan-Feb;31(1):55-60.
3
Photodynamic therapy for corneal neovascularization.用于角膜新生血管化的光动力疗法。
Ophthalmic Surg Lasers. 1998 Oct;29(10):832-8.
4
Photodynamic therapy with verteporfin in a rabbit model of corneal neovascularization.在兔角膜新生血管模型中使用维替泊芬进行光动力疗法。
Invest Ophthalmol Vis Sci. 2003 Jul;44(7):2954-8. doi: 10.1167/iovs.02-0572.
5
Polymeric micelle nanoparticles for photodynamic treatment of head and neck cancer cells.用于光动力治疗头颈癌细胞的聚合物胶束纳米颗粒。
Otolaryngol Head Neck Surg. 2010 Jul;143(1):109-15. doi: 10.1016/j.otohns.2010.03.032.
6
Photodynamic effects of SIM01, a new sensitizer, on experimental brain tumors in rats.新型敏化剂SIM01对大鼠实验性脑肿瘤的光动力效应。
Surg Neurol. 2007 Sep;68(3):255-63; discussion 263. doi: 10.1016/j.surneu.2006.10.072. Epub 2007 Jun 4.
7
Photodynamic Therapy Leads to Time-Dependent Regression of Pathologic Corneal (Lymph) Angiogenesis and Promotes High-Risk Corneal Allograft Survival.光动力疗法可导致病理性角膜(淋巴)血管生成随时间推移而消退,并促进高危角膜移植存活。
Invest Ophthalmol Vis Sci. 2017 Nov 1;58(13):5862-5869. doi: 10.1167/iovs.17-22904.
8
Evaluation of the new photosensitizer Tookad (WST09) for photodynamic vessel occlusion of the choroidal tissue in rabbits.新型光敏剂Tookad(WST09)用于兔脉络膜组织光动力血管闭塞的评估。
Invest Ophthalmol Vis Sci. 2006 Dec;47(12):5437-46. doi: 10.1167/iovs.06-0532.
9
Argon laser photodynamic therapy of human corneal neovascularization after intravenous administration of dihematoporphyrin ether.静脉注射二血卟啉醚后对人角膜新生血管进行氩激光光动力治疗。
Am J Ophthalmol. 2006 Mar;141(3):524-529. doi: 10.1016/j.ajo.2005.11.003.
10
Simultaneous but not prior inhibition of VEGF165 enhances the efficacy of photodynamic therapy in multiple models of ocular neovascularization.同时而非预先抑制VEGF165可增强光动力疗法在多种眼部新生血管模型中的疗效。
Invest Ophthalmol Vis Sci. 2008 Feb;49(2):662-70. doi: 10.1167/iovs.07-0195.

引用本文的文献

1
Dendrimers in Corneal Drug Delivery: Recent Developments and Translational Opportunities.树枝状聚合物在角膜药物递送中的应用:最新进展与转化机遇
Pharmaceutics. 2023 May 25;15(6):1591. doi: 10.3390/pharmaceutics15061591.
2
Modulation of the 20S Proteasome Activity by Porphyrin Derivatives Is Steered through Their Charge Distribution.卟啉衍生物通过其电荷分布来调节 20S 蛋白酶体的活性。
Biomolecules. 2022 May 24;12(6):741. doi: 10.3390/biom12060741.
3
Micelles Based on Lysine, Histidine, or Arginine: Designing Structures for Enhanced Drug Delivery.
基于赖氨酸、组氨酸或精氨酸的胶束:用于增强药物递送的结构设计
Front Bioeng Biotechnol. 2021 Sep 27;9:744657. doi: 10.3389/fbioe.2021.744657. eCollection 2021.
4
Ocular Drug Delivery Barriers-Role of Nanocarriers in the Treatment of Anterior Segment Ocular Diseases.眼部给药屏障——纳米载体在眼前节眼部疾病治疗中的作用
Pharmaceutics. 2018 Feb 27;10(1):28. doi: 10.3390/pharmaceutics10010028.
5
Can nanotechnology potentiate photodynamic therapy?纳米技术能增强光动力疗法吗?
Nanotechnol Rev. 2012 Mar;1(2):111-146. doi: 10.1515/ntrev-2011-0005.
6
Clinical correlates of common corneal neovascular diseases: a literature review.常见角膜新生血管疾病的临床关联:文献综述
Int J Ophthalmol. 2015 Feb 18;8(1):182-93. doi: 10.3980/j.issn.2222-3959.2015.01.32. eCollection 2015.
7
Controlled ocular drug delivery with nanomicelles.纳米胶束用于眼部药物的控释。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2014 Sep-Oct;6(5):422-37. doi: 10.1002/wnan.1272. Epub 2014 Jun 2.
8
Dendrimeric systems and their applications in ocular drug delivery.树枝状聚合物体系及其在眼部药物递送中的应用。
ScientificWorldJournal. 2013 Dec 14;2013:732340. doi: 10.1155/2013/732340. eCollection 2013.
9
Nanotechnology in corneal neovascularization therapy--a review.纳米技术在角膜新生血管治疗中的应用——综述。
J Ocul Pharmacol Ther. 2013 Mar;29(2):124-34. doi: 10.1089/jop.2012.0158. Epub 2013 Feb 20.
10
Shining light on nanotechnology to help repair and regeneration.纳米技术之光,助力修复与再生。
Biotechnol Adv. 2013 Sep-Oct;31(5):607-31. doi: 10.1016/j.biotechadv.2012.08.003. Epub 2012 Aug 21.